Business · 17/11/2017Updated: 10/17/2026 · 1 min read
FDA Announces Public Comment Period for Proposed Collection of Information on Meetings with Office of Orphan Products Development
Summary
The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to meetings with the Office of Orphan Products Development, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →